CLINICAL_TRIALS
trial_result
· 2015-02-26
Clinical Trial Update: Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) [Phase 3]
Summary
A Phase 3 study comparing Vidaza (azacitidine) with conventional care regimens in acute myeloid leukemia has completed. Results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2015-02-26